Loading company…
Riskpilot
← Back to search
Sign in
Get full access
AZL APOTEK AS
AS
Active
Org 931985442
Søbstadvegen 14, 7088 Heimdal
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
7 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 20,6M
EBITDA margin
3.0%
+10900% vs 2023
Equity ratio
7.5%
Financial strength
Net profit 2024
NOK 364K
+6572% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 20,6M
—
EBITDA
NOK 607K
+10900%
Net profit
NOK 364K
+6572%
Total assets
NOK 5,1M
+21014%
Equity
NOK 388K
+1491%
Employees
7
—
Company information
Legal name
AZL APOTEK AS
Org number
931985442
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
30. august 2023
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Drive apotek og farmasøytiske vare, samt det som naturlig står i forbindelse med dette.
Contact
Address
Søbstadvegen 14, 7088 Heimdal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Trondheim
All Norway companies
Revenue
NOK millions
0M
6M
12M
18M
24M
0M
2023
21M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
20 558
Staff expenses
−0
−3 781
EBITDA
−6
607
Depreciation & amort.
−0
−120
EBIT
−6
487
Net financials
0
−21
Profit before tax
−6
466
Tax
−0
103
Net profit
−6
364
Balance sheet
NOK thousands
Item
2023
2024
Total assets
24
5 148
Equity
24
388
Long-term debt
0
236
Short-term debt
0
4 525
Total debt
0
4 760
Financial ratios
5-year trend
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
2023
2024
Equity ratio
7.5%
This company
38.2%
Market median
-80% vs market
2023
2024
Return on equity
93.7%
This company
18.4%
Market median
+409% vs market
2023
2024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
2023
2024
Asset turnover
3.99×
This company
1.12×
Market median
+256% vs market
2023
2024
Debt / equity
12.27×
This company
0.62×
Market median
-1879% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
NH
Nosheen Hinna Saleem
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
HM
Hafiz Muhammad Umer
Board of Directors
2024
MK
Muhammad Kashif Mumtaz
Chairman
2024
MF
Muhammad Furqan
Chairman
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of AZL APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Nosheen Hinna Saleem
Chief Executive Officer
0 companies
Hafiz Muhammad Umer
Board of Directors
0 companies
Muhammad Kashif Mumtaz
Chairman
0 companies
Muhammad Furqan
Chairman
0 companies